Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
DMC Biotechnologies produces bio-based chemicals using fermentation.
IMIO develops biological products for agriculture that use naturally occurring microorganisms to support crop production and soil health.
EnginZyme is a biotechnology company that creates biomanufacturing techniques for the sustainable production of common goods.
HighLife is a trans-catheter mitral valve replacement company.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
Neurent Medical is a medical device startup that develops non-surgical treatments for inflammatory sino-nasal diseases.
Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.
Bionyra Pharma is a clinical-stage biopharmaceutical startup developing next-generation biologics for severe immune-mediated inflammation.
Ingenix is building an AI Co-pilot for generating real-time hypotheses on clinical endpoints values and adverse events.
Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
P2 Science produces bio-based chemicals from renewable materials for consumer and industrial use.
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.
Biotalys is an AgTech company that employs its proprietary AGROBODY™ technology platform to develop crop protection products.
Abivax develops medicines that alter the body's natural immune system mechanisms.
AFYREN is a green chemistry company that produces biobased, low-carbon carboxylic acids through sustainable fermentation technology.
A French biotechnology company that uses precision fermentation to produce real dairy products, accessible to everyone.
Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
BrightHeart is a medical technology startup that is developing artificial intelligence software.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.
Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.
Sofinnova Partners has invested in 150 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Medical Device, Therapeutics, Manufacturing. The firm invests across 24 different industry categories.
Among tracked funding rounds, Bionyra received $165.0M in a Series A round. Sofinnova Partners's total known invested capital is $7.1B.
Sofinnova Partners's average investment size is $47.4M across its portfolio of 150 companies.
Recent Sofinnova Partners portfolio additions include DMC Biotechnologies, IMIO, EnginZyme, HighLife, One Biosciences. These companies were founded in 2020 or later.